No 10Y consistency score for revenue — its stored periods are half-year spaced, so quarter-over-same-quarter consistency is not computed.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annualized revenue (TTM) · by quarter, last 16
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T14:01:58.246Z. Latest historical point 2026-06-23. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for HeartSciences Inc. (HSCS) stock was $3.47 as of Oct 6, 2026, 10:00 AM EDT, down 20.47% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +17.8% · 3-year avg -51.4%/yr
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI).
Medical - Devices · Southlake, TX
LATEST PRICE
$3.47
52-WEEK RANGE
$1.63 - $5.25
BETA
1.77
% FROM 52W HIGH
-33.95%
MARKET CAP
$7.49M
DIVIDEND YIELD
Never paid
N/A
PE RATIO
trailing TTM
N/A
PE RATIO (FWD)
forward FY estimate
N/A
P/B RATIO
N/A
P/S RATIO
TTM
N/A
P/OCF RATIO
TTM
N/A
EV/EBITDA
TTM
N/A
DEBT / EQUITY
N/A
REVENUE TTM
$8.67K
GROSS MARGIN TTM
N/A
NET PROFIT MARGIN TTM
N/A
REVENUE GROWTH TTM
TTM vs prior TTM
N/A
REVENUE CAGR 3Y
N/A
REVENUE CAGR 5Y
N/A
TTM TOTAL RETURN
+17.75%
3Y TOTAL RETURN
annualized (CAGR)
-51.42%
5Y TOTAL RETURN
annualized (CAGR)
N/A
Next Earnings Date
Dec 21, 2026
76 days away
EPS Estimate
-0.62
Revenue Est.
$100000.00
Last Quarter Results
EPS
$-0.86
vs Estimate
$-0.72
Revenue
$2100.00
vs Estimate
$100000.00
Consensus Rating
Based on 1 analyst
Average Price Target
$12.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $-0.64 | $-0.62 | $-0.60 | 1 |
| Quarter ending Jan 2027 | $-0.65 | $-0.61 | $-0.57 | 1 |
| Quarter ending Apr 2027 | $-1.25 | $-0.56 | $0.06 | 1 |
| Quarter ending Jul 2027 |
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1HSCS | $7.49M | $3.47 | -20.47% | +17.75% | N/A | N/A | N/A |
| 2LGVN | $7.49M | $2.46 | -1.99% | -67.97% | -62.60% | N/A | vs HSCS |
| 3INM | $7.37M | $1.34 | +0.93% | -41.77% | -71.98% | -52.81% | vs HSCS |
| 4CURX | $7.17M | $5.06 | +2.02% | -68.03% | N/A | N/A | vs HSCS |
| 5CNSP | $7.83M | $5.36 | +1.13% | -40.68% | -91.63% | N/A | vs HSCS |
| 6GTBP | $7.84M | $6.21 | +0.81% | -61.33% | -73.13% | -68.76% | vs HSCS |
+246.1% upside
Low
$12.00
Current
$3.47
High
$12.00
| $-1.28 |
| $-0.57 |
| $0.07 |
| 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-2.55 | $-2.46 | $-2.37 | 1 |
| FY 2027 | $-1.87 | $-1.75 | $-1.63 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $14285.00 | $100000.00 | $195238.00 | 1 |
| Quarter ending Jan 2027 | $499.00 | $5000.00 | $10000.00 | 1 |
| Quarter ending Apr 2027 | $1428.00 | $10000.00 | $19523.00 | 1 |
| Quarter ending Jul 2027 | $14285.00 | $100000.00 | $195238.00 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $950.00 | $17100.00 | $33250.00 | 1 |
| FY 2027 | $2.99M | $3.15M | $3.31M | 1 |
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
